Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Jude

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|August 16, 2024
De novo design of miniprotein antagonists of cytokine storm inducersBuwei Huang, Brian Coventry, Marta T Borowska, et al.
Nature|December 8, 2022
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptidesXinbo Yang, Lee I Garner, Ivan V Zvyagin, et al.
Cell|July 28, 2018
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC BindingLeah V Sibener, Ricardo A Fernandes, Elizabeth M Kolawole, et al.
Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2026
Design of solubly expressed miniaturized SMART MHCsWilliam L White, Hua Bai, Chan Jhong Kim, et al.
Nature|January 11, 2019
De novo design of potent and selective mimics of IL-2 and IL-15Daniel-Adriano Silva, Shawn Yu, Umut Y Ulge, et al.
Nature Chemical Biology|April 6, 2023
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffoldsHuilin Yang, Umut Y Ulge, Alfredo Quijano-Rubio, et al.
Nature|January 24, 2022
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAMTobias V Lanz, R Camille Brewer, Peggy P Ho, et al.
Nature|March 25, 2022
Design of protein-binding proteins from the target structure aloneLongxing Cao, Brian Coventry, Inna Goreshnik, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|August 16, 2024
De novo design of miniprotein antagonists of cytokine storm inducersBuwei Huang, Brian Coventry, Marta T Borowska, et al.
Nature|December 8, 2022
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptidesXinbo Yang, Lee I Garner, Ivan V Zvyagin, et al.
Cell|July 28, 2018
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC BindingLeah V Sibener, Ricardo A Fernandes, Elizabeth M Kolawole, et al.
Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2026
Design of solubly expressed miniaturized SMART MHCsWilliam L White, Hua Bai, Chan Jhong Kim, et al.
Nature|January 11, 2019
De novo design of potent and selective mimics of IL-2 and IL-15Daniel-Adriano Silva, Shawn Yu, Umut Y Ulge, et al.
Nature Chemical Biology|April 6, 2023
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffoldsHuilin Yang, Umut Y Ulge, Alfredo Quijano-Rubio, et al.
Nature|January 24, 2022
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAMTobias V Lanz, R Camille Brewer, Peggy P Ho, et al.
Nature|March 25, 2022
Design of protein-binding proteins from the target structure aloneLongxing Cao, Brian Coventry, Inna Goreshnik, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Pageof 7